From: Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
AJCC response
Number of patients (N = 183)
Number
Percent (%)
CR
22
12.0
PR
123
67.2
NR
38
20.8